Human TACI/TNFRSF13B Antibody, R&D Systems™

Mouse Monoclonal Antibody has been used in 2 publications

Catalog Number	Mfr. No.	Quantity
MAB174SP	R&D Systems MAB174SP	25 μg
MAB174100	R&D Systems MAB174100	100 μg
MAB174500	R&D Systems MAB174500	500 μg

Description

TACI/TNFRSF13B/CVID Monoclonal specifically detects TACI/TNFRSF13B/CVID in Human samples. It is validated for Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction, ELISA Capture (Matched Antibody Pair).

Specifications

• Antigen: TACI/TNFRSF13B/CVID
• Dilution: Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL, Blockade of Receptor-ligand Interaction, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL
• Classification: Monoclonal
• Host Species: Mouse
• Target Species: Human
• Gene Accession No.: O14836
• Gene ID (Entrez): 23495
• Immunogen: Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B Ser2-Thr166 Accession # O14836
• Primary or Secondary: Primary
• Reconstitution: Reconstitute at 0.5 mg/mL in sterile PBS.
• Test Specificity: Detects human TACI/TNFRSF13B in ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse TACI or recombinant human BCMA is observed.

• Clone: 165609
• Applications: Western Blot, Immunohistochemistry, Blockade of Receptor-ligand Interaction, ELISA
• Conjugate: Unconjugated
• Regulatory Status: RUO
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative
• Gene Alias: CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF13B, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
• Gene Symbols: TNFRSF13B
• Isotype: IgG1
• Purification Method: Protein A or G purified from hybridoma culture supernatant
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

For Research Use Only